CAS 1416334-69-4

Formel: C29H27FN6O4S

InChl: InChI=1S/C29H27FN6O4S/c1-39-28-27(41(37,38)34-24-5-3-2-4-23(24)30)17-20(18-32-28)19-6-11-25-26(16-19)36(29(31)33-25)22-9-7-21(8-10-22)35-12-14-40-15-13-35/h2-11,16-18,34H,12-15H2,1H3,(H2,31,33)

InChI Key: AJOGHKUZDLYXKS-UHFFFAOYSA-N

SMILES: COC1=C(C=C(C=N1)C2=CC3=C(C=C2)N=C(N3C4=CC=C(C=C4)N5CCOCC5)N)S(=O)(=O)NC6=CC=CC=C6F

GSK-A1

CAS: 1416334-69-4

Formel: C₂₉H₂₇FN₆O₄S

Reinheit: 98.03%

Molekulargewicht: 574.6259

Ref: IN-DA00A18N

GSK-A1

CAS: 1416334-69-4

Ref: 7W-GW0843

GSK-A1

CAS: 1416334-69-4

GSK-A1 is a specific inhibitor of PI4KA, also inhibited calcium-driven PRL secretion without affecting calcium signaling and Prl expression.

Formel: C₂₉H₂₇FN₆O₄S

Reinheit: 97.97% - 98.97%

Farbe und Form: Solid

Molekulargewicht: 574.626

Ref: TM-T27499

5-(2-Amino-1-(4-morpholinophenyl)-1H-benzimidazol-6-yl)-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide

CAS: 1416334-69-4

Formel: C₂₉H₂₇FN₆O₄S

Reinheit: 99+%

Molekulargewicht: 574.63

Ref: IN-DG01308705

Pi4Ka inhibitor-A1

CAS: 1416334-69-4

Pi4Ka inhibitor-A1 is a peptide that is used in research as an activator or inhibitor of protein interactions. Pi4Ka inhibitor-A1 may be used to study the function of ion channels and receptors, and has been shown to inhibit the function of ligand-gated ion channels, such as nicotinic acetylcholine receptors. It is also used in pharmacology to study the binding of ligands, such as neurotransmitters, to receptors. This peptide has high purity and a CAS number of 1416334-69-4.

Formel: C₂₉H₂₇FN₆O₄S

Reinheit: Min. 95%

Molekulargewicht: 574.6 g/mol

Ref: 3D-RGC33469